Cargando…

Development and validation of a screening instrument for cognitive fluctuation in patients with neurocognitive disorder with Lewy bodies (NCDLB): the Mayo Fluctuations Scale-Thai version

BACKGROUND: Prevalence of neurocognitive disorder with Lewy bodies (NCDLB) is low in Asian populations, which may partially reflect its diagnostic difficulty. The Mayo Fluctuations Scale, a short questionnaire that evaluates cognitive fluctuation, has been shown to significantly differentiate NCDLB...

Descripción completa

Detalles Bibliográficos
Autores principales: Thaipisuttikul, Papan, Chittaropas, Pitchayawadee, Wisajun, Pattaraporn, Jullagate, Sudawan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211087/
https://www.ncbi.nlm.nih.gov/pubmed/30582111
http://dx.doi.org/10.1136/gpsych-2018-000001
_version_ 1783367264429408256
author Thaipisuttikul, Papan
Chittaropas, Pitchayawadee
Wisajun, Pattaraporn
Jullagate, Sudawan
author_facet Thaipisuttikul, Papan
Chittaropas, Pitchayawadee
Wisajun, Pattaraporn
Jullagate, Sudawan
author_sort Thaipisuttikul, Papan
collection PubMed
description BACKGROUND: Prevalence of neurocognitive disorder with Lewy bodies (NCDLB) is low in Asian populations, which may partially reflect its diagnostic difficulty. The Mayo Fluctuations Scale, a short questionnaire that evaluates cognitive fluctuation, has been shown to significantly differentiate NCDLB from Alzheimer’s disease. AIM: This study aimed to develop the Mayo Fluctuations Scale-Thai version and assess its validity to screen NCDLB in an elderly population. METHODS: The Mayo Fluctuations Scale was translated into Thai. The process involved back-translation, cross-cultural adaptation, field testing of the prefinal version, as well as final adjustments. From all patients attending the Psychiatric and Memory Clinic at Ramathibodi Hospital, 135 patients accompanied by their primary caregivers were included. Caregivers were interviewed by research assistants using a four-item scale, and psychiatrists determined patients’ diagnosis based on the diagnostic and statistical manual of mental disorders (DSM)-5 criteria. Evaluations performed by psychiatrists and research assistants were blinded. RESULTS: Seventeen participants had been diagnosed with major NCDLB. At a cut-off score of 2 or over, the Mayo Fluctuations Scale exhibited excellent performance to differentiate major NCDLB from other major neurocognitive disorders (NCDs), with a sensitivity of 94.1% and a specificity of 71.4%, and acceptable performance to differentiate mild NCDLB from other mild NCDs, with a sensitivity of 60% and a specificity of 93.1%. CONCLUSION: The Mayo Fluctuations Scale-Thai version is an excellent screening tool for major NCDLB and an acceptable tool that may be used with other additional tests for mild NCDLB. The tool is practical for use in memory and psychiatric clinics. Further validation studies in participants with other specific clinical conditions are required.
format Online
Article
Text
id pubmed-6211087
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-62110872018-12-21 Development and validation of a screening instrument for cognitive fluctuation in patients with neurocognitive disorder with Lewy bodies (NCDLB): the Mayo Fluctuations Scale-Thai version Thaipisuttikul, Papan Chittaropas, Pitchayawadee Wisajun, Pattaraporn Jullagate, Sudawan Gen Psychiatr Original Research BACKGROUND: Prevalence of neurocognitive disorder with Lewy bodies (NCDLB) is low in Asian populations, which may partially reflect its diagnostic difficulty. The Mayo Fluctuations Scale, a short questionnaire that evaluates cognitive fluctuation, has been shown to significantly differentiate NCDLB from Alzheimer’s disease. AIM: This study aimed to develop the Mayo Fluctuations Scale-Thai version and assess its validity to screen NCDLB in an elderly population. METHODS: The Mayo Fluctuations Scale was translated into Thai. The process involved back-translation, cross-cultural adaptation, field testing of the prefinal version, as well as final adjustments. From all patients attending the Psychiatric and Memory Clinic at Ramathibodi Hospital, 135 patients accompanied by their primary caregivers were included. Caregivers were interviewed by research assistants using a four-item scale, and psychiatrists determined patients’ diagnosis based on the diagnostic and statistical manual of mental disorders (DSM)-5 criteria. Evaluations performed by psychiatrists and research assistants were blinded. RESULTS: Seventeen participants had been diagnosed with major NCDLB. At a cut-off score of 2 or over, the Mayo Fluctuations Scale exhibited excellent performance to differentiate major NCDLB from other major neurocognitive disorders (NCDs), with a sensitivity of 94.1% and a specificity of 71.4%, and acceptable performance to differentiate mild NCDLB from other mild NCDs, with a sensitivity of 60% and a specificity of 93.1%. CONCLUSION: The Mayo Fluctuations Scale-Thai version is an excellent screening tool for major NCDLB and an acceptable tool that may be used with other additional tests for mild NCDLB. The tool is practical for use in memory and psychiatric clinics. Further validation studies in participants with other specific clinical conditions are required. BMJ Publishing Group 2018-08-21 /pmc/articles/PMC6211087/ /pubmed/30582111 http://dx.doi.org/10.1136/gpsych-2018-000001 Text en © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research
Thaipisuttikul, Papan
Chittaropas, Pitchayawadee
Wisajun, Pattaraporn
Jullagate, Sudawan
Development and validation of a screening instrument for cognitive fluctuation in patients with neurocognitive disorder with Lewy bodies (NCDLB): the Mayo Fluctuations Scale-Thai version
title Development and validation of a screening instrument for cognitive fluctuation in patients with neurocognitive disorder with Lewy bodies (NCDLB): the Mayo Fluctuations Scale-Thai version
title_full Development and validation of a screening instrument for cognitive fluctuation in patients with neurocognitive disorder with Lewy bodies (NCDLB): the Mayo Fluctuations Scale-Thai version
title_fullStr Development and validation of a screening instrument for cognitive fluctuation in patients with neurocognitive disorder with Lewy bodies (NCDLB): the Mayo Fluctuations Scale-Thai version
title_full_unstemmed Development and validation of a screening instrument for cognitive fluctuation in patients with neurocognitive disorder with Lewy bodies (NCDLB): the Mayo Fluctuations Scale-Thai version
title_short Development and validation of a screening instrument for cognitive fluctuation in patients with neurocognitive disorder with Lewy bodies (NCDLB): the Mayo Fluctuations Scale-Thai version
title_sort development and validation of a screening instrument for cognitive fluctuation in patients with neurocognitive disorder with lewy bodies (ncdlb): the mayo fluctuations scale-thai version
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211087/
https://www.ncbi.nlm.nih.gov/pubmed/30582111
http://dx.doi.org/10.1136/gpsych-2018-000001
work_keys_str_mv AT thaipisuttikulpapan developmentandvalidationofascreeninginstrumentforcognitivefluctuationinpatientswithneurocognitivedisorderwithlewybodiesncdlbthemayofluctuationsscalethaiversion
AT chittaropaspitchayawadee developmentandvalidationofascreeninginstrumentforcognitivefluctuationinpatientswithneurocognitivedisorderwithlewybodiesncdlbthemayofluctuationsscalethaiversion
AT wisajunpattaraporn developmentandvalidationofascreeninginstrumentforcognitivefluctuationinpatientswithneurocognitivedisorderwithlewybodiesncdlbthemayofluctuationsscalethaiversion
AT jullagatesudawan developmentandvalidationofascreeninginstrumentforcognitivefluctuationinpatientswithneurocognitivedisorderwithlewybodiesncdlbthemayofluctuationsscalethaiversion